biote Corp. (NASDAQ:BTMD - Free Report) - Investment analysts at B. Riley issued their Q3 2025 earnings per share (EPS) estimates for shares of biote in a research report issued to clients and investors on Thursday, March 13th. B. Riley analyst J. Van. Sinderen anticipates that the company will post earnings per share of $0.10 for the quarter. The consensus estimate for biote's current full-year earnings is $0.75 per share. B. Riley also issued estimates for biote's Q4 2025 earnings at $0.10 EPS.
Separately, Craig Hallum lowered their price objective on biote from $12.00 to $8.00 and set a "buy" rating for the company in a research note on Thursday, March 13th.
View Our Latest Stock Analysis on biote
biote Trading Up 1.8 %
NASDAQ BTMD traded up $0.07 during mid-day trading on Friday, reaching $4.07. 231,877 shares of the company's stock traded hands, compared to its average volume of 176,962. biote has a 1-year low of $3.04 and a 1-year high of $8.44. The company has a fifty day simple moving average of $4.92 and a 200-day simple moving average of $5.53. The company has a market cap of $221.15 million, a price-to-earnings ratio of 15.65 and a beta of 1.07.
Insider Buying and Selling at biote
In other biote news, major shareholder Guines Llc acquired 750,000 shares of the stock in a transaction on Thursday, March 13th. The stock was purchased at an average price of $3.22 per share, for a total transaction of $2,415,000.00. Following the purchase, the insider now directly owns 3,820,938 shares in the company, valued at $12,303,420.36. This trade represents a 24.42 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 13.90% of the stock is owned by insiders.
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in BTMD. Price T Rowe Associates Inc. MD acquired a new position in shares of biote in the 4th quarter worth approximately $67,000. Commonwealth Equity Services LLC acquired a new position in shares of biote in the 4th quarter worth approximately $68,000. Public Employees Retirement System of Ohio acquired a new position in shares of biote in the 4th quarter worth approximately $69,000. Intech Investment Management LLC acquired a new position in shares of biote in the 4th quarter worth approximately $71,000. Finally, SG Americas Securities LLC acquired a new position in shares of biote in the 4th quarter worth approximately $76,000. Institutional investors and hedge funds own 21.68% of the company's stock.
About biote
(
Get Free Report)
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.
Recommended Stories
Before you consider biote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and biote wasn't on the list.
While biote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
